The program addresses the general lack of efficiency in changing promising targets from genomics study into effective new medicines, potentially achieving significant period and cost savings that will increase European competitiveness in the biotechnology Industry at many levels. The project integrates four companies in a highly interactive workflow which will give a model establishing a strong position for biotech accuracy technology platforms. In comparison to the original approach, PONT can undertake pre-clinical drug development with a rather than a sequential approach parallel. This helps you to save years when it comes to the trials.. 2.5 million euros assists fight liver cancer The fight liver cancer, among the leading causes of cancer death worldwide, has been helped by 2.Remains the best of all developed countries, based on the authors.. AP analysis reveals big jump in compensation bundle for insurance exec The Associated Press/ABC Information: Aetna Chairman, CEO Tag Bertolini Sees 2012 Total Payment Climb 26 Percent Aetna Inc. Missed an earnings goal last year, therefore the health insurer cut the performance-based reward it awarded Chairman and CEO Mark T. Bertolini. But the executive's total compensation rose 26 % in 2012 still. Bertolini, 56, received payment valued at $13.2 million this past year, regarding to an Associated Press analysis of the Hartford, Conn., business's annual proxy filing with the Securities and Exchange Commission. That's up from regarding $10.6 million in 2011 . This article was reprinted from kaiserhealthnews.org with permission from the Henry J.